Effect of Time to Intravenous Thrombolysis in Ischemic Stroke Patients With NIHSS Score 0–2 at Admission
Acta Neurologica Scandinavica · 2026-01 · 2026 (1)
DOI: 10.1155/ane/2042787 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Neurologica Scandinavica, online erschienen am 29.07.2026. Verfasst von Torunn Varmdal und 4 weiteren Autor:innen. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Schlaganfall
Abstract (Originalsprache)
Background
There is rising evidence that intravenous thrombolysis (IVT) in stroke patients presenting with mild neurological deficits may not be beneficial. However, there is limited knowledge on time to IVT treatment in relation to functional outcome in this population.
Aims
The aim of the study is to examine the effect of time to IVT treatment in a real‐world setting among patients with a National Institutes of Health Stroke Scale (NIHSS) score of 0–2 at admission.
Methods
This observational study included ischemic stroke patients registered in the NHR in 2014‐2022. We categorized patients into four groups: no IVT, or IVT within 90, 91–180, or > 180 min after symptom onset. Functional outcome 3 months post stroke was compared across groups using ordinal logistic regression, with outcomes measured by modified Rankin Scale (mRS). Missing values were handled using multiple imputation, and our primary analysis was performed on a recombined dataset of 40 imputed datasets.
Results
The results are presented as the pooled odds across 40 imputed datasets (mean n = 7722). The odds of having a higher mRS score 3 months post stroke (i.e., a worse outcome) was 0.81 (95% CI 0.71–0.92) for patients receiving IVT within 90 min after symptom onset, increasing to 0.90 (CI 0.80–1.02) for IVT between 91 and 180 min, and 0.98 (CI 0.85–1.13) for IVT > 180 min after symptom onset.
Conclusions
When administered within 90 min of stroke onset, IVT treatment is associated with beneficial functional outcome for stroke patients presenting with NIHSS 0–2. However, the favorable effect of IVT appears to diminish progressively with increasing time from symptom onset. In our cohort, 3.2% of patients treated with IVT experienced symptomatic intracranial hemorrhage (sICH). Careful consideration of the risk‐benefit ratio is advised before administering IVT for patients with mild neurological deficits, particularly in those presenting more than 90 min after stroke onset.
Zitieren
APA
Varmdal, T., Blindheimsvik, M. A., Lydersen, S., Fjærtoft, H., & Indredavik, B. (2026). Effect of Time to Intravenous Thrombolysis in Ischemic Stroke Patients With NIHSS Score 0–2 at Admission. Acta Neurologica Scandinavica, 2026(1). https://doi.org/10.1155/ane/2042787
Vancouver
Varmdal T, Blindheimsvik MA, Lydersen S, Fjærtoft H, Indredavik B. Effect of Time to Intravenous Thrombolysis in Ischemic Stroke Patients With NIHSS Score 0–2 at Admission. Acta Neurologica Scandinavica. 2026;2026(1). doi:10.1155/ane/2042787
BibTeX
@article{Varmdal2026,
author = {Varmdal, Torunn and Blindheimsvik, Martin André and Lydersen, Stian and Fjærtoft, Hild and Indredavik, Bent},
title = {Effect of Time to Intravenous Thrombolysis in Ischemic Stroke Patients With NIHSS Score 0–2 at Admission},
journal = {Acta Neurologica Scandinavica},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/ane/2042787}
}
EUVIMED